PGx Requires Continuous Development of Clinical Strategies, more from Mary Relling of St. Jude, Track Chair on January 27, 2023
“Clinical implementation of pharmacogenetic testing is no longer held back primarily by a lack of evidence supporting its use but remains relatively rare for practical reasons. In the next 3 years, implementation can be facilitated by continued development of clinical guidelines and informatics tools that can work across platforms, increased uptake by professional societies, continued […]
Join Over 2,000 healthcare leaders at PMWC Silicon Valley 2023 on January 25-27, 2023
PMWC January 25-27, 2023’s Conference theme, “COVID-19 Learnings for Precision Medicine: Collaboration = Breakthroughs“, is a call to action for all researchers, healthcare professionals, commercial and government representatives, to come together and – inspired and empowered by the learnings and successes related to us having faced the COVID-19 pandemic – take ownership and continue the […]
Hear Aida Habtezion, Pfizer’s CMO June 28: Pfizer’s Bivalent, Next-Gen mRNA COVID vaccine development & full-day COVID-19 Dx Vx & Tx Track @PMWC June 28-30
“One of the key lessons learned from the pandemic has been to recognize and focus on advancing impactful science that can quickly be translated into clinical use. Our initial partnership with BioNTech was to develop a more flexible influenza vaccine and our team of experts had been studying the mRNA platform for many years. By […]
Note from Sean Khozin to Susan D’Elia, Can AI-Powered Medical Imaging Reclassifying Disease Categories? Let’s Discuss at PMWC June 28-30
In recent years, we’ve made significant advances on the technology and algorithm development front, while old incentive structures and legacy organizational behaviors continue to represent the most critical barriers to unlocking the full potential of AI in biomedical research and healthcare delivery. “Adding the outputs of omics pipelines to AI-powered interpretation of medical imaging can […]
Join the Track Chaired by Invitae: Comprehensive Profiling, an Essential Tool in Clinical Practice and Disease Research
The extent of genomic information utilization in medical practice is strongly linked to the advances in genomic technologies and sciences. More specifically, recent progress in genomic/genetic screening technologies has made such application an essential tool in clinical practice and for disease research, especially for cancer genomics. While we also see a rise in their use […]
Join the PMWC 2022 Track 3, June 28 Session Breakdown: Wider Adoption of Precision Medicine and NGS in Oncology at the Santa Clara Convention Center
Precision medicine promises a revolutionary understanding of cancers based on genetic alterations instead of primary tumor location and appearance. As the number of druggable gene aberrations and predictive biomarkers grow in oncology, next-generation sequencing (NGS) technologies have increasingly been substituted for (or added to) the more conventional techniques (e.g., single-gene testing, routine molecular pathology). Given the decreasing costs […]
Just published: Long-Read Sequencing Unlocks The Final Gaps In The Human Genome
Nearly 20 years after the Human Genome Project sequenced 92% of the human genome, scientists just published the first truly complete genome. The effort involved an unprecedented, grassroots collaboration of scientists around the world who applied novel long-read sequencing technologies to sort through massive, previously unmapped strands of DNA located primarily in the dense centers of […]
Gene and Cell Therapy is at an Inflection Point. Join me June 28-30 at PMWC 2022 Silicon Valley
Recent advancements of gene and cell therapy offer a glimpse of what’s to come. Be it previously approved CAR-T therapies (Yescarta, Kymriah, Tescartus), AAV (adeno-associated virus) transgene delivery (Luxtuma, Zolgensma), or investigational gene editing (in vivo EDIT-101, ex vivo CTX001, or allogeneic T cells) and universal donor cell therapies (allogeneic cell products, such as engineered […]
See Why Liquid Biopsy is the Fastest Growing Area in the Medical Diagnostics Field in the Coming Decade at PMWC22
One of the most exciting developments in the life sciences and diagnostics is the advancement of liquid biopsy, which is why we are dedicating a Track to it, June 29th, at PMWC 2022 Silicon Valley (June 28-30). Gleaning meaningful insights from tiny amounts of circulating tumor DNA (ctDNA), the premise underpinning liquid biopsy tests, has […]
Join Dean Julie Johnson for the PGx Track, June 30 @PMWC -Details Provided
Pharmacogenomic (PGx) relies on scientific breakthroughs in our understanding of how a person’s unique molecular and genetic profile influences susceptibility to and progression of certain diseases and predicts which medical treatments will likely be safe and effective, and which ones will not. Consequently, PGx information in those instances has the power to reduce the likelihood […]
